Arix Bioscience (LON:ARIX) Hits New 12-Month Low at $120.00

Arix Bioscience PLC (LON:ARIX) reached a new 52-week low on Monday . The stock traded as low as GBX 120 ($1.57) and last traded at GBX 121 ($1.58), with a volume of 26001 shares traded. The stock had previously closed at GBX 121 ($1.58).

The business has a 50-day moving average price of GBX 130.23. The firm has a market cap of $164.02 million and a PE ratio of 4.22.

Arix Bioscience Company Profile (LON:ARIX)

Arix Bioscience plc, formerly known as Perceptive Bioscience Investments Limited, is a venture capital firm specializing in seed, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, medical innovation comprising healthcare and life sciences.

Recommended Story: Trade Deficit

Receive News & Ratings for Arix Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arix Bioscience and related companies with's FREE daily email newsletter.